Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H. McAlpine’s multiple sclerosis. 3rd ed. London: Churchill Livingstone, 1998.
Compston A, Coles A. Multiple sclerosis.Lancet 2002; 359: 1221–31.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
Torrance G.W. Uttility approach to mesuring helth-related quality of life. J Chron Dis 1987; 40: 593-600.
Katz S. The science of quality of life. J Chr Des 1987; 6: 459-462.
Fisk J, Brown M, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005; 76: 58–63.
Amato MP, Portaccio E. Clinical outcome measures in multiple sclerosis. J Neurol Sci 2007; 259: 118-122.
Nortvedt MV, Riise T. The use of quality of life measures in MS research. Mult Scler 2003; 9: 63-72.
Ascherio A, Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327–2.
Rudick RA, Miller D, Clough JD, Gragg LA, Farmer RG. Quality of life in multiple sclerosis: Comparison with infalamatory bowel disease and rheumatoid arthritis. Arch Neurol 1992; 49: 1237-1242.
Vickrey BG, Hays RD, Genovese BJ, et al. Comparison of a generic disease targeted health related quality of life measures for mltiple sclerosis. J Clin Epidemiol 1997; 50: 557-569.
Kurtzke JF. Rating neurologic instrument in multiple sclerosis: An expandede disability status scale (EDSS). Neurology 1983; 33: 1444-52.
Hamilton H. Development of a rating scale for primary depressive illnes. Br J Soc Clin Psychol 1967; 6: 278-286.
Hamilton H. The assessment of anxiety status by rating. Br J Med Psychol 1959; 32: 50.
Rudick RA, Miller DM. Haelth–related quality of life in multiple sclerosis: current evidence, measurment, and effects of disease severity and treatment. CNS Drugs 2008; 22: 827-839.
Miller A, Dishon S. Health-related quality of life in multiple sclerosis. The impact of dysability, gender and employment status. Qual Life Res 2006; 15: 259-71.
Amato M, Rossi F, Ponziani, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: The impact of depression, fatigue end disability. Mult Scler 2001; 7: 340-344.
Pittock SJ, Mayer WT, McClelland Rc, et al. Quality of life is favorable for most patients with multiple sclerosis: a population based cohort study. Arch Neurol 2004; 61: 679-86.
Tepavcevic DK, Pekmezovic T, Drulovic J. Quality of life assessment in patients with multiple sclerosis. Vojnosanit Pregl. 2009; 6: 645-56.
Morales-Gonzales JM, Benito-Leon J, Rivera-Navarro J, Mitchel AJ. A systematic approach to analyse haelth-related quality of life in multiple sclerosis: the GEDMA study. Mult Scler 2004; 10: 47-54.
Casetta I, Riise T, Nortvedt WM, Economou NT, De Geunaro R, Fazio P, Cesnik E, Govoni V, Granieri E. Gender diffrences in health-related quality of life in multiple sclerosis. Mult Scler 2009; 15: 1339-46.
Simmons RD, Tribe KL, McDonald EA. Living with multiple sclerosis: longitunal changesin employment and the importance of symptom menagement. J Neurol 2010; 257: 926-36.
Messmer Uccelli M, Specchia C, Battaglia MA, Miller DM. Factors that influence the employment status of people with multiple sclerosis: a multi national study. J Neurol 2009; 256: 1989-96.
Buchanan RS, Zhu LL, Schiffer R, Radin DE James W. Rural-urban analyses of helth-related quality of life among people with multiple sclerosis. J Rural Haelth 2008; 24: 244-52.
Pekmezovic T, Tepavcevic DK, Kostic J, Drulovic J.Validation and cross-cultural adaptation of the disease specific questionnaire MSQoL-54 in Serbian multple sclerosis patients sample. Qual Life Res 2007; 16: 1383-7.
Abbas D, Gehanno JF, Caillard JF, Beuret F. Caracteristic of patients suffering from multiple sclerosis according to professional situation. Ann Readapt Med Phys 2008; 51: 386-93.
Idiman E, Uzunel F, Ozakbas S. Cross-cultural adaptation and validation of MSQoL-54 in Turkish multiple sclerosis sample. J Neurol Sci 2006; 240: 77-80.
Starks H, Morris MA, Yorkston KM, Gray RF, Johnson KL. Being in-or out-of-sync: Couples’ adaptation to change in MS. Disabil Rehabil 2010; 32: 196-206.
Blinder JA. A case study of a married couple living with multiple sclerosis. Rehabil Nurs 2004; 29: 183-6.
Solari A, Filippini G, Mendozzi L, et al. Validation of Italian Multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999; 67: 158-162.
Benito-Leon, J, Morales, JM, Rivera-Navarro, J, Mitchell, A. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil 2003; 25: 1291–1303.
Pfennigns L, Cohen L, Ader H, et al. Exploring differences betwen subgroup of multiple sclerosis patients in health related quality of life. J Neurol 1999; 246: 587-591.
Wynia K, Middel B, van Dijk SP, De Kayser JH. The impact of disability on quality of life in MS. Mult Scler 2008 Aug; 14: 972-80.
Gorreti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S, amato M. P. Coping strategies, psychological variables, and their relationship whit quality of life in multiple sclerosis Neurolog Sci 2009; 20: 128-33.
Lode K, Larsen JP, Bru E, Klevan G, Myhr KM, Nyland H . Patient information and coping styles in multiple sclerosis. Multiple Sclerosis 2007; 13: 783-791.
Pugliatti M, Riise T, Nortvedt MW, Carpentras G, Sotgiu MA, Sotgiu S, RosaliG. Self-preceved physical functioning and health status among fuly ambulatory multiple sclerosis patients. J Neurol 2008; 255: 157-162.
Murphy N, Confavreux C, Haas J, Konig J, Roullet O, Sailer M, Swash M, Merof JL. Quality of life in multiple sclerosis patients in France, Germany and United Kingdom. Cost of MS Study Group. J Neurl Neurosurg Psychyatry 1998; 6: 460-6.
Robinson D Jr, Zhao N, Gabhang T, Kin LL, Cella D, Revichi D. Health perceptions and clinical characteristics of relapsing-remitting multiple scleosis patients: baseline data from an international clinical trial. Curr Med Res Opin 2009; 25: 1121-30.
Canadian Burden of Illnes Study Group. Burden of illnes of multiple sclerosis. II. Quality of life. Can J Neurol Sci 1998; 25: 31-38.
Fruehwald S, Loefller-Stastka R, Eher B, et al. Depression and health related quality of life in multiple sclersis. Acta Neurol Scand 2001; 104: 257-261.
Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: Mesauring the disease effects more broadly. Neurology 1999; 53: 1098-1103.
Brunet DG, Hopman WM, Singer MA, Edgen CM, McKenzie TA. Measurment of HRQoL in multiplesclerosis patients. Can J Neurol Sci 2000; 23: 99-103.
Rothwell PM, McDowell Z, Dorman PS. Doctors and patients don’t agree: Cross sectional study of patients’and’doctors perceptions and assessment of disability in multiplesclerosis. BMJ 1997; 314: 1580-1583.
Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Sexual disfunction in multiple sclerosis: a case control study. I. Freqency and comparison of groups. Mult Scler. 1999; 5: 418-27.
Zorzon M, Zivadinov R, Monti Bragadin L, Morreti R, De Masi R, Nasuelli D, Cazzato G Sexual dsfunction in multiple sclerosis: a 2-yeahr follow-up study. J Neurol Sci 2001; 187: 1-5.
Nortvedt MW, Riise T, Myhr KM, Landtblom AM, Bakke A, Nyland HI. Reduced haelth related quality of life among multiple sclerosis patients with sexual disturbance an bladder dysfunction. Mult Scler 2001; 7: 231-5.
Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Asian K. Multiple sclerosis patients with and withaut sexual dysfunction: are there any differences? Mult Scler. 2006; 12: 209-14.
Tepavcevic DK, Kostić J, Basuroski ID, Stojsavljevic N, Pekmezovic T, Drulovic J. The impact of sexual dysfunction on the quality of life measured by MSQL-54 in patients with multiple sclerosis. Mult Scler 2008; 14: 1131-6.
Benito- Leon J, Morales JM, Riviera-Navarro J. Haelth related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 2002 ; 9: 497-502.
Glanz B, Healy BC, Rintell DP, Jaffin SK, Bakshi R, Weiner HL. The associatin between cognitive impairment and quality of life in patients with early multiple sclerosis. J Neurol Sci. 2010; 290: 75-9.
Cutajar R, Ferriani E; Scandellari C, Sabatinni L; Trocino C, Marchello LP; Stecchi S. Cognitive function and quality of life in multiple sclerosis. J Neurovir 2000 May; 6: 186-90.
Zipoli V, Goretti B, Hakiki B, Simense G, Sorbi S, Portaccio E, Amato MP . Cognitive impairment predict conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler. 2010 ; 16: 62-7.
Amato MP, Portaccio E, Stromilo ML, et al. cognitive assessment and quantitative magnetic resonance metrics can help to identifay benign multiple sclerosis. Neurology 2008; 71: 632-8.
Rugieri RM, Palermo R, Vitello G, Genuso M, Sellipani N, Piceoli F. Cognitive impairment in patients suffering from relapsing remitting multiple sclerosis with EDSS< 3.5. Acta Neurol Scand 2003;108: 323-326.
Filipi M, Alberoni M, Martinelli V, et al. Influenze of clinical variables on neuropsychological prformance in multiple sclerosis. Eur Neurol 1999; 34: 324-328.
Moller A, Wiedemann G, Rohde V, Bachmund H, Sonntag A. Correlats of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 1994; 89: 117-121.
Kujala P, Portin R, Ruutainen J. The progress of cognitive decline in multiple sclerosis. Brain 1997; 120: 289-297.
Rao SM, Leo GJ, Ellington L, et al.Cognitive dysfunction in multiple sclerosis, II. Impact on employment and social functioning. Neurology 1991; 41: 692-696.
De Groot V, Beckerman H, Lankhors G, Polman CH, Bouter LM. The initial course of daily functioning in multiple sclerosis: a three year a follow-up study. Mult Scler 2005; 11: 713-8.
Riviera –Navarro J, Benito-Leon J, Oreja-Guevara C, et al. Burden and health related quality of life of Spanish caregivers of person with multiple sclerosis. Mult Scler 2009; 15: 1347-55.
Gold SM, Monch A, Schulz H, Schulz KH, Hesler C. Cognitive impairment in MS does not affect reliability and validity of self-report health measures. Mult Scler 2003; 9:404-410.
Bronnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N. Suicide among Danes with multiple sclerois. J Neurol Neurosurg Psych. 2008; 76:1457-1459.
Feinstein A. Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol 2007; 254: 73-76.
Rothwell PM. Quality of life in multiple sclerosis. J Neurol Neorusurg Psychiatry. 1998; 65: 433.
Arnett PA, Rao SM, Bernardin L, et al. Quality of life in multiple sclerosis: the impact of depression, fatigue and dissability. Mult Scler 2001; 76: 340-344.
Feinstein A. Depression associated with multiplesclerosis: an etiological. Can J Psychiatry 1998; 40: 573-576.
McIvor G, Riklan M, Reznikoff M. Depression in multiplesclerosis as afunction of lenght and severity of illness, age, remissions, and precived of socialsupport. J Clin Psychol. 1989; 40: 1028-1033.
Joffe RT, Lippert GP, Gras TA et al. Mood disorder and multiplesclerosis. Arch Neurol 1987; 44: 376-378.
Minden SL, Orar I, Reich P. Depression in multiple sclerosis. General Hosp Psychiatry 1987; 9: 426-434.
Gorreti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S, Amato M. P. Coping strategies, psychological variables, and their relationship whit quality of life in multiple sclerosis Neurolog Sci 2009; 12: 528-531.
Lobentantz IS, Asenbaum S,Vass K,Sauter C, Klosch G, Kogllegger H, Kristoferitsch W, Zeitlhofer J. Factor influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 2004; 110: 6-13.
Kern S, Schrempf W, Schneider W, et al. Neurological disability, psychological distres, and health-related quality of life in multiple sclerosis patients within three years after diagnosis. Mult Scler 2009; 15: 752-8.
Janssens AC, van Doorm PA, de Boer JB, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Multiple sclerosis 2003; 9: 397-403.
D’Alisa S, Miscio G, Bando S, et al. Depression is the main determinant in quality of life in multiple sclerosis; a classification-regression (CART) study. Disabil Rehabil 2006; 28: 307-314.
Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76: 469-475.
Mohr DC, Goodkin DE, Gutti N, et al. Depression, coping strategies, and level of neurological impairment in multiple sclerosis. Mult Scler 1997; 3:254-258.
Lynch SG, Kroencke DC, Dennev DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainity, coping and hope. Mult Scler 2001; 7: 411-416.
Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in MS patients. Mult Scler 2007; 13: 67-72.
Poder K, Ghatavik K,Fish J at al. Social anxiety in multiple sclerosis clinic population. Mult Scler 2009; 15: 393-398.
Montel SR, Bungener C. Coping and quality of life in one hundred and thirty five subjests with multiple sclerosis. Mult Scler 2007; 13: 393-401.
Galeazzi GM, Ferrari S, Giaroli G et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005; 26: 255-262.
Benedict RH, Wahling E, Bakshi R, Fishman I, Munchauer F, Zivadinov R, Weinstock-Guttman B. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality and behavioral change. J Neurol Sci 2005; 23: 29-34.
Putzki N, Fischer J, Gotwald K, et al. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol 2009; 16: 713-20.
Janardhan V, Bakshi R. Qulity of life in patients with multiple sclerosis; the impact of fatigue and depression. J Neurol Sci 2002; 205: 51-8.
Freeman JA, Thompson AJ, Fitzpatric R, et al. Interferon – β 1b in the treatment of secondary progressive MS: Impact of Quality of life. Neurology 2001; 57: 1870-5
Cohen JA, Cutter GR, Fischer JS, et al. Benefit of Interferon – β 1a on MSFC progression in secondary progressive MS. Neurology 2002; 59: 679-87.
Simone IL, Ceccarelli A, Tortorella C, et. al. Influence of Interferon – β treatment on quality of life in multiple sclerosis patinents. Health Qual Life Outcomes 2006; 4: 96.
Lily O, McFadden E, Hensor E, et al. Disease – specific quality of life in multiple sceloris: the effect of disease modifying treatment. Mult Scler 2006; 12: 808-13.
Vermersch P, de Seze J, Delisse B, Lemaire S , Stojkovic T. Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment. Mult Scler 2002; 8: 377–381.
Zivadinov R, Zorzon M, Tommasi MA, et al. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. J Neurol Sci 2003; 216: 113–118.
Rudick RA, Miller D, Hass S, et al. Health relatet quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol 2007; 62: 335-46.
Spain LA, Tubridy N, Kilpatrick TJ, Adams SJ, Holmes AC. Ilnes perception and health related quality of life in multiple sclerosis. Acta Neurol Scand 2007; 116: 293-299.